Home
Conditions
Treatments
Trials
Explore
🏠
/
treatments
/
Autologous chimeric antigen receptor T cell transfusing agent targeting CD22
/
mega-study
Autologous chimeric antigen receptor T cell transfusing agent targeting CD22